IS THE ACRAL-LENTIGINOUS MELANOMA (ALM) MORE MALIGNANT THAN THE SUPERFICIAL SPREADING MELANOMA (SSM) IN A HIGH-RISK LOCATION - A MATCHED-PAIR COMPARISON OF 113 EACH ALM AND SSM IN A MULTICENTER STUDY

被引:13
作者
BREUNINGER, H
KOHLER, C
DREPPER, H
BASTIAN, B
BROCKER, EB
GOHL, J
GROTH, W
HERMANEK, P
HOHENBERGER, W
LIPPOLD, A
KOLMEL, K
LANDTHALER, M
PETERS, A
TILGEN, W
机构
[1] FACHKLIN HORNHEIDE MUNSTER,MUNSTER,GERMANY
[2] UNIV WURZBURG,HAUT KLIN,W-8700 WURZBURG,GERMANY
[3] UNIV ERLANGEN NURNBERG,CHIRURG KLIN,W-8520 ERLANGEN,GERMANY
[4] UNIV COLOGNE,CHIRURG KLIN,W-5000 COLOGNE 41,GERMANY
[5] UNIV GOTTINGEN,CHIRURG KLIN,W-3400 GOTTINGEN,GERMANY
[6] UNIV REGENSBURG,DERMATOL KLIN,W-8400 REGENSBURG,GERMANY
[7] UNIV HEIDELBERG,CHIRURG KLIN,W-6900 HEIDELBERG,GERMANY
[8] GERMAN CANC RES CTR,W-6900 HEIDELBERG 1,GERMANY
来源
HAUTARZT | 1994年 / 45卷 / 08期
关键词
ACRAL-LENTIGINOUS MELANOMA; SUPERFICIAL SPREADING MELANOMA; PROGNOSIS; MATCHED PAIR STUDY;
D O I
10.1007/s001050050120
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Even today, the prognosis of acrallentiginous melanoma (ALM) remains a controversial topic. We present a large case study including all known factors relevant for prognosis. 113 ALMs in 3616 melanoma patients were paired as precisely as possible with their twins, i.e. with 113 superficial spreading melanomas (SSM) from a group of 619 SSMs with high-risk location. The ALMs and SSMs were equivalent in tumor thickness, patient gender and mode of treatment. The follow-up period was for at least 5 years. The 5-year Kaplan-Meier survival curve in both groups are identical. The poor prognosis often ascribed to ALM results from the prognostic factor location. ALM should therefore be regarded as acral localized melanoma.
引用
收藏
页码:529 / 531
页数:3
相关论文
共 19 条
[1]  
BALCH CM, 1991, CUTANEOUS MELANOMA, P165
[2]   MELANOMA WITHIN A SOUTHWESTERN HISPANIC POPULATION [J].
BLACK, WC ;
GOLDHAHN, RT ;
WIGGINS, C .
ARCHIVES OF DERMATOLOGY, 1987, 123 (10) :1331-1334
[3]   SUBUNGUAL MALIGNANT-MELANOMA - CLINICOPATHOLOGICAL FEATURES OF 100 CASES [J].
BLESSING, K ;
KERNOHAN, NM ;
PARK, KGM .
HISTOPATHOLOGY, 1991, 19 (05) :425-429
[4]  
BONERANDI JJ, 1987, ANN DERMATOL VENER, V114, P1141
[5]  
CASCINELLI N, 1986, CANCER, V57, P441, DOI 10.1002/1097-0142(19860201)57:3<441::AID-CNCR2820570306>3.0.CO
[6]  
2-S
[7]  
COHEN PJ, 1988, SKIN CANC RECOGNITIO, P99
[8]   PROGNOSTIC FACTORS FOR PATIENTS WITH CLINICAL STAGE-1 MELANOMA OF INTERMEDIATE THICKNESS (1.51-3.99 MM) - A CONCEPTUAL-MODEL FOR TUMOR-GROWTH AND METASTASIS [J].
DAY, CL ;
MARTIN, C ;
LEW, RA ;
HARRIS, MN ;
KOPF, AW ;
FITZPATRICK, TB ;
HARRIST, TJ ;
GOLOMB, FM ;
POSTEL, A ;
HENNESSEY, P ;
GUMPORT, SL ;
RAKER, JW ;
MALT, RA ;
COSIMI, AB ;
WOOD, WC ;
ROSES, DF ;
GORSTEIN, F ;
RIGEL, D ;
FRIEDMAN, RJ ;
MINTZIS, MM ;
SOBER, AJ .
ANNALS OF SURGERY, 1982, 195 (01) :35-43
[9]  
DREPPER H, IN PRESS CANCER
[10]  
JOHNSON OK, 1985, CANCER-AM CANCER SOC, V55, P1107, DOI 10.1002/1097-0142(19850301)55:5<1107::AID-CNCR2820550528>3.0.CO